01 February 2025 : Editorial
Editorial: Current Approaches to Screening for Lung Cancer in Smokers and Non-Smokers
Dinah V. Parums F 1*DOI: 10.12659/MSM.948255
Med Sci Monit 2025; 31:e948255
Table 1 International Association for the Study of Lung Cancer (IASLC) five-year (2023–2027) roadmap for lung cancer screening using low-dose computed tomography (LDCT) [4].
| Nine Recommendations from the IASLC Five-Year (2023–2027) Roadmap |
|---|
| Establishment of universal quality indicators for lung cancer screening programs |
| Establishment of evidence-based criteria to identify individuals who have never smoked but are at increased risk for developing lung cancer |
| Recommendations for follow-up of incidentally identified lung nodules with management protocols to complement lung cancer screening |
| Integration of diagnostic and prognostic biomarkers and the use of artificial intelligence (AI) in LDCT screen-detected lung lesions |
| Standardized high-quality AI performance protocols to reduce screening costs by improving resource utilization and reducing radiologist reporting time |
| Introduction of personalized lung LDCT screening intervals based on individual lung cancer risk |
| Continued research to develop evidence to support cost-effective clinical management of other identified abnormalities detected on screening using LDCT |
| Improvement and monitoring of equitable access to lung cancer screening services |
| Establishment of a globally shared education resource for radiologists involved in lung cancer screening to ensure high-quality reporting of LDCT lung imaging |